Line Holten Reimer
Directeur/Membre du Conseil chez Rehfeld Medical ApS
Profil
Line Holten Reimer is currently the Director at Rehfeld Medical ApS since 2017.
Prior to this, Ms. Reimer held Director positions at several firms including Alkalon A, Medbroker ApS, Reapplix A, Aros Pharma ApS, Minervax ApS, MedicoSelskabet September 2014 ApS, Oracain ApS, TagAway Devices ApS, and Dep-Xplora ApS.
Ms. Reimer also worked as an Investment Manager at SEED Capital Management I from 2003 to 2014.
Ms. Reimer is a graduate of the University of Vienna and the University of Copenhagen.
Postes actifs de Line Holten Reimer
Sociétés | Poste | Début |
---|---|---|
Rehfeld Medical ApS
Rehfeld Medical ApS Packaged SoftwareTechnology Services Rehfeld Medical ApS develops and distributes software and information technology solutions for clinical processes. It provides platform, such as SCAUT, to support treatment of remotely monitored heart patients. The company was founded by Jonas Jermiin Ravn Moll in 2014 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | 01/10/2017 |
Anciens postes connus de Line Holten Reimer
Sociétés | Poste | Fin |
---|---|---|
SEED Capital Management I/S
SEED Capital Management I/S Investment ManagersFinance SEED Capital Management I/S is an Independent Venture Capital firm founded in 2004. The company is headquartered in Copenhagen, Denmark. | Private Equity Investor | 31/12/2014 |
MedicoSelskabet September 2014 ApS
MedicoSelskabet September 2014 ApS Medical SpecialtiesHealth Technology MedicoSelskabet September 2014 ApS is a holding company that develops medical devices for cardiovascular sensing. Its scheme is based on a concept that does not interfere with the state of the patient. It improves the method of measuring hypertension and suitable for ambulatory continuous measurements. Its also involves in the repair of communication equipment. The company was founded by Ole Kjerulf Jensen and Lars Lading on June 14, 2002 and is headquartered in Hellerup, Denmark. | Directeur/Membre du Conseil | - |
Dep-Xplora ApS
Dep-Xplora ApS BiotechnologyHealth Technology Dep-Xplora ApS provides drugs in the development of depots for joint injections. Its non-steroidal anti-inflammatory drugs are widely used as rescue medicine to relieve moderate to severe postoperative pain after minor joint surgery and to alleviate inflammatory pain associated with various arthritis conditions. The firms prodrug approach taken enables establishment of drug concentration to manage pain and inflammation at the site of action and at the same time minimizes the risk of systemic adverse events. The company was founded by Jens Hansen and Claus Selch Larsen in 2012 and is headquartered in Lejre, Denmark. | Directeur/Membre du Conseil | - |
Aros Pharma ApS
Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Aros Pharma ApS is a holding company that develops medicine targeting unmet needs within pain relief, infectious disease, inflammation, respiratory diseases, and immuno-suppressed patients. It is a biotech company that focuses on clinical development of a novel therapy for the treatment of gastrointestinal pain. The firm is developing a new pain relief therapy based on a small molecule (PPC-5650) that is a specific inhibitor of the ASIC 1a receptor (Acid Sensing Ion Channel subtype 1a). Its therapy is currently being tested in two phase I trials targeting pain in patients who suffer from Irritable Bowel Syndrome (IBS) or non-erosive Gastroesophageal Reflux Disease (NERD). The company was founded in 2009 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | - |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | - |
Formation de Line Holten Reimer
University of Vienna | Graduate Degree |
University of Copenhagen | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 11 |
---|---|
SEED Capital Management I/S
SEED Capital Management I/S Investment ManagersFinance SEED Capital Management I/S is an Independent Venture Capital firm founded in 2004. The company is headquartered in Copenhagen, Denmark. | Finance |
Alkalon A/S
Alkalon A/S Pharmaceuticals: MajorHealth Technology Alkalon A/S engages in the development of pharmaceutical industry. It focuses on developing and commercializing medicated chewing gum formulations. The firm also owns portfolio of nicotine gums approved for smoking cessation and smoking reduction. The company was founded by Bo Tandrup in 2007 and is headquartered in Copenhagen, Denmark. | Health Technology |
Medbroker ApS
Medbroker ApS BiotechnologyHealth Technology Medbroker ApS develops technologies for bioproduction. It engages in research and development on biotechnology. The firm commercializes globally through industrial partnerships and licensing. It has technologies such as Macrobeads for static and dynamic cell culture, Bioreactors for Bioproduction, Scaffolds for cell culture, disposable Biosensors for labware, and Microwells for three-dimensional cell culture. The company was founded on January 2, 2009 and is headquartered in Gadstrup, Denmark. | Health Technology |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Distribution Services |
Aros Pharma ApS
Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Aros Pharma ApS is a holding company that develops medicine targeting unmet needs within pain relief, infectious disease, inflammation, respiratory diseases, and immuno-suppressed patients. It is a biotech company that focuses on clinical development of a novel therapy for the treatment of gastrointestinal pain. The firm is developing a new pain relief therapy based on a small molecule (PPC-5650) that is a specific inhibitor of the ASIC 1a receptor (Acid Sensing Ion Channel subtype 1a). Its therapy is currently being tested in two phase I trials targeting pain in patients who suffer from Irritable Bowel Syndrome (IBS) or non-erosive Gastroesophageal Reflux Disease (NERD). The company was founded in 2009 and is headquartered in Copenhagen, Denmark. | Health Technology |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
MedicoSelskabet September 2014 ApS
MedicoSelskabet September 2014 ApS Medical SpecialtiesHealth Technology MedicoSelskabet September 2014 ApS is a holding company that develops medical devices for cardiovascular sensing. Its scheme is based on a concept that does not interfere with the state of the patient. It improves the method of measuring hypertension and suitable for ambulatory continuous measurements. Its also involves in the repair of communication equipment. The company was founded by Ole Kjerulf Jensen and Lars Lading on June 14, 2002 and is headquartered in Hellerup, Denmark. | Health Technology |
Oracain ApS
Oracain ApS Pharmaceuticals: MajorHealth Technology Oracain ApS develops oral pain medications based on known active compounds. It is developing a novel pharmaceutical product for pain associated with oral mucositis and other complex conditions. The company was founded by Ove Andersen in 2011 and is headquartered in Lyngby, Denmark. | Health Technology |
TagAway Devices ApS
TagAway Devices ApS Pharmaceuticals: MajorHealth Technology TagAway Devices ApS operates as a medical research and development company. The firm develops self-care devices for the removal of skin tags without bleeding, scarring, pain or infection. The company was founded by Staffan Sundström and is headquartered in Hørsholm, Denmark. | Health Technology |
Dep-Xplora ApS
Dep-Xplora ApS BiotechnologyHealth Technology Dep-Xplora ApS provides drugs in the development of depots for joint injections. Its non-steroidal anti-inflammatory drugs are widely used as rescue medicine to relieve moderate to severe postoperative pain after minor joint surgery and to alleviate inflammatory pain associated with various arthritis conditions. The firms prodrug approach taken enables establishment of drug concentration to manage pain and inflammation at the site of action and at the same time minimizes the risk of systemic adverse events. The company was founded by Jens Hansen and Claus Selch Larsen in 2012 and is headquartered in Lejre, Denmark. | Health Technology |
Rehfeld Medical ApS
Rehfeld Medical ApS Packaged SoftwareTechnology Services Rehfeld Medical ApS develops and distributes software and information technology solutions for clinical processes. It provides platform, such as SCAUT, to support treatment of remotely monitored heart patients. The company was founded by Jonas Jermiin Ravn Moll in 2014 and is headquartered in Copenhagen, Denmark. | Technology Services |